Who we are

In June 2018 the R Consortium granted funding for a PSI AIMS SIG initiative to create an ‘online R package validation repository’. Following the R in Pharma Conference in August 2018, membership of the group was expanded and as of October 2018, the group includes participants from:

  • Abbvie - Greg Cicconetti
  • Amgen - Bella Feng, Min Lee
  • Astellas - Michael Carniello
  • Bayer - Karl Brand
  • Biogen - Dan Boisvert, Bob Engle, Eric Milliman, Nate Mockler
  • BioMarin Pharmaceutical Inc. - Dharmesh Desai
  • Boehringer-Ingelheim - Matthias Trampisch
  • Cognigen Corporation - Nash Delcamp
  • Eli Lilly - Eric Nantz
  • FDA - Tomas Drgon, Paul Schuette, Mat Soukup
  • Galapagos NV - Paul Meyvisch
  • Genentech - Doug Kelkhoff
  • GSK - Tilo Blenk, Andy Nicholls, Alexander Lock-Achilleos
  • IQVIA - Thomas Brechenmacher, Jack Elkes
  • InModelia - Patrice Kiener
  • Johnson & Johnson - Paulo Bargo, Mark Bynens, Satish Murthy, Karma Tarap
  • Linux Foundation - John Mertic
  • Merck KGaA/EMD Serono - Martin Gregory, Juliane Manitz
  • MSD - Keaven Anderson, Rinki Jajoo, Edward Lauzier, Yilong Zhang
  • MRC-BSU - Kevin Kunzmann
  • Novartis - Xiao Ni, Huilei Xu
  • Novonordisk - Claus Dethlefsen
  • Pfizer - John Sims
  • Phastar - Lyn Taylor
  • PPD - Craig McIlloney
  • Quanticate - Niccolo Bassani
  • RCPE - Phillip Clarke
  • Rho, Inc. - Rebecca Krouse, Steve Noga
  • Roche - Alun Bedding, James Black, Markus Elze, Jules Hernandez-sanchez, Reinhold Koch, Kieran Martin
  • RStudio - Phil Bowsher, Joseph Rickert
  • Sanofi - Patric Stracke
  • Scharp - Anthony Williams
  • Servier - Mickael Guedj, Yann Robert
  • SQN Clinical - Chris Toffis

If your organisation is not listed above and you are interested in getting involved please contact psi.aims.r.validation@gmail.com.